Johns Hopkins researchers using limited proteolysis mass spectrometry identified over 200 types of misfolded proteins associated with age-related cognitive decline in rats, suggesting amyloid-beta and tau are part of a broader proteopathy landscape. This comprehensive structural proteomics approach may reveal novel therapeutic targets for Alzheimer’s and dementia beyond classical amyloid pathways, addressing a major societal challenge in neurodegenerative disease management.